vaginitis--%20trichomoniasis,%20candidiasis,%20bacterial%20vaginosis
VAGINITIS: TRICHOMONIASIS, CANDIDIASIS, BACTERIAL VAGINOSIS

Trichomoniasis is caused by a flagellated protozoan, Trichomonas vaginalis. It is always sexually transmitted.

Bacterial vaginosis is the most common cause of vaginitis, vaginal discharge or malodor. It results from overgrowth of anaerobic bacteria.

Vulvovaginal candidiasis is caused by overgrowth of yeasts where 70-90% of cases are secondary to Candida albicans. It most commonly occurs when the vagina is exposed to estrogen (ie, reproductive years, pregnancy) and may be precipitated by antibiotic use.

Patient Education

  • Patient needs to be informed about the nature of the infection and the importance of taking full course of the medication
  • Counsel patients on possible complications of vaginitis and therapy
    • Bacterial vaginosis is associated with post-procedure pelvic inflammatory disease (PID), IUD insertion or other instrumentation, vaginal cuff cellulitis, and pregnancy-related problems (eg late miscarriage, preterm birth, premature rupture of membranes, chorioamnionitis, postpartum endometritis)
    • Trichomoniasis is associated with increased human immunodeficiency virus (HIV) transmission and adverse pregnancy outcomes (eg preterm delivery, premature rupture of membranes, low birth weight)
  • Inform patients with bacterial vaginosis to avoid vaginal douching, use of shower gel and antiseptic agents or shampoo in the bath tub
  • Advise patients with vulvovaginal candidiasis to avoid tight fitting synthetic clothes and use of local irritants
  • Antifungal vaginal creams used for VVC treatment can damage latex condoms, cervical caps, and diaphragms 
  • Consider alternative contraceptive method in women with recurrent vulvovaginal candidiasis who are utilizing combined hormonal contraception
  • Advise Trichomoniasis patients on how to lower their risk of acquiringsexually transmitted infections
    • Tailor counseling to the patient’s specific risk factors
    • Abstinence, condom use
    • Careful selection of partners
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Infectious Diseases - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
15 Sep 2016
Tigecycline therapy produces favourable outcomes in severe Clostridium difficile infection (sCDI), says a study.
Roshini Claire Anthony, 22 May 2018

The combined use of piperacillin and tazobactam does not appear to be a suitable alternative to meropenem for patients with bloodstream infections caused by ceftriaxone-resistant Escherichia coli (E. coli) or Klebsiella pneumoniae (K. pneumoniae), according to results of the MERINO* trial.

Pearl Toh, 28 Dec 2017
The addition of low oxygen levels measured by pulse oximetry to the three signs delineated in the current diagnostic model for pneumonia in primary care setting derived by van Vugt, which include fever, tachycardia, and crackly breath sounds on auscultation, can add value to diagnostic precision and help general practitioners (GPs) differentiate pneumonia from less serious infections, a study suggests.
26 Sep 2017
Ceftazidime-avibactam appears to offer a reasonable alternative to colistin in the treatment of Klebsiella pneumoniae carbapenemase (KPC)-producing carbapenem-resistant Enterobacteriaceae (CRE) infections, according to a study.